Pacira BioSciences (PCRX) Current Leases (2019 - 2025)
Historic Current Leases for Pacira BioSciences (PCRX) over the last 7 years, with Q3 2025 value amounting to $9.7 million.
- Pacira BioSciences' Current Leases rose 606.03% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year increase of 606.03%. This contributed to the annual value of $8.9 million for FY2024, which is 97.72% up from last year.
- Latest data reveals that Pacira BioSciences reported Current Leases of $9.7 million as of Q3 2025, which was up 606.03% from $9.6 million recorded in Q2 2025.
- In the past 5 years, Pacira BioSciences' Current Leases ranged from a high of $9.7 million in Q3 2025 and a low of $5.5 million during Q1 2021
- In the last 5 years, Pacira BioSciences' Current Leases had a median value of $8.9 million in 2024 and averaged $8.4 million.
- Its Current Leases has fluctuated over the past 5 years, first tumbled by 2593.18% in 2021, then soared by 4570.23% in 2022.
- Over the past 5 years, Pacira BioSciences' Current Leases (Quarter) stood at $7.9 million in 2021, then increased by 15.59% to $9.1 million in 2022, then decreased by 3.51% to $8.8 million in 2023, then increased by 0.98% to $8.9 million in 2024, then rose by 9.69% to $9.7 million in 2025.
- Its Current Leases stands at $9.7 million for Q3 2025, versus $9.6 million for Q2 2025 and $9.4 million for Q1 2025.